Tilray has additional GMP certification for international cannabis exports

by Team Inc.

04-02-2020-Tilray has additional GMP certification for international cannabis export

With the new Tilray licenses, the company's international export capacity can be expanded with the authorized production of medicinal cannabis flower and oil products.

Tilray, a global pioneer in the research, cultivation, production and distribution of cannabis, recently announced its wholly owned subsidiary Tilray Portugal and received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards for its production facility in Cantanhede (Portugal).

GMP certification

The GMP certification has been issued by Infarmed, the Portuguese National Authority for Medicines and Health Products. This is the second GMP certification for Tilray Portugal, which allows the production of GMP certified cannabis flower and oil products for export to international markets. Brendan Kennedy, CEO of Tilray: “We are pleased with the continued momentum of our growth strategy across Europe with this additional GMP certification for Tilray's EU campus in Portugal. This allows us to export a wider range of medical cannabis products to international patients, partners and markets. Our international strategy is an important part of driving long-term profitability and shareholder value. ”

Tilray Portugal

Tilray's EU campus in Portugal is a versatile production facility. It has facilities for cultivation, research and quality control labs, and processing and packaging materials for medical marijuana and its distribution. Tilray's EU campus also serves as a hub to support Tilray's clinical research and product development across Europe. Several harvests are expected in the coming months.

In May 2019, Tilray Portugal received its first production license and initial GMP certification, enabling the company to manufacture and export dried cannabis. In September 2019, Tilray Portugal completed its first export to Germany. To date the largest bulk shipment of medicinal cannabis in Europe. With additional GMP certification announced today, Tilray will be able to deliver pharmaceutical grade dried flowers and oils as well as finished medicinal cannabis products internationally.

“We now have two GMP certified facilities to support our global expansion strategy,” said Sascha Mielcarek, Tilray's Managing Director in Europe. “We are pleased to be able to export our leading medical cannabis flower and oil products to international markets. We will continue to expand our reach to give patients access to Tilray medical cannabis products. Proudly produced in Europe. ”

Tilray has established sales and distribution arrangements to supply medical cannabis through major pharmaceutical distribution channels across Germany and other European markets. Thanks to these arrangements, patients will soon have access to Tilray's medicinal cannabis products.

Read more healtheurope.eu (Source, EN)

Related Articles

Comments

[adrate banner="89"]